BrachySciences

BrachySciences develops, markets, sells, and distributes radioactive seeds, as well as delivery systems and auxiliary equipment used in brachytherapy implants. The company provides research and development services for prostate cancer treatment. It offers seeds, components, and needles; applicator KITs, preloaded sterile cartridges; strands and spacers; and TargetScan, an ultrasound device designed to improve the accuracy of brachytherapy implants. Its services include implant training programs, reimbursement services, CME programs, and direct-to-consumer initiatives. The company was founded in 2005 and is headquartered in Oxford, Connecticut. As of December 31, 2015, BrachySciences operated as a subsidiary of Theragenics Corp.